Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Brain cancer article

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Jun 21, 2022 2:14pm

209 Views

Post# 34771925

RE:RE:Brain cancer article

I have been disappointed in how long it has taken to get into testing. Is the answer the company is using their next generation of PDCs for GBM and NSCLC and they have yet to be approved?

I have wondered if and when those new PDCs have been approved will TLT be able to use them in the treatment of bladder cancer? I assume yes and if so patients would actual benefit from even better results while TLT would benefit from longer patent protection on the new drugs.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing